In this Review, Khan and colleagues discuss the benefits and challenges of including pragmatism in the design, conduct and interpretation of randomized controlled trials (RCTs) for cardiovascular disease and highlight selected ongoing and completed cardiovascular RCTs that incorporate a pragmatic design.
- Muhammad Shariq Usman
- Harriette G. C. Van Spall
- Muhammad Shahzeb Khan